-transparent.png){kind=logo}
1. Drug metabolism was assessed by the disappearance rate of antipyrine as measured in saliva. Results were expressed in terms of both clearance and half life. 2. Basal measurements of antipyrine disappearance rate were performed in seven non-smokers and six smokers. After administration of glutethimide 250 mg daily for 7 days a second measurement of antipyrine disappearance rate was made. 3. Glutethimide enhanced antipyrine metabolism in both smokers and non-smokers. The degree of change in both groups was similar. 4. A similar study was carried out with a smaller dose (125 mg) of glutethimide. There was no significant difference between smokers and non-smokers.5. The data are consistent with smoking and chronic drug ingestion having additive effects on enhancement of hepatic drug metabolism.
W G Cooksley, and
G C Farrell, and
G A Cash, and
L W Powell
January 1979,
The Western journal of medicine,
W G Cooksley, and
G C Farrell, and
G A Cash, and
L W Powell
March 1983,
Clinical pharmacology and therapeutics,
W G Cooksley, and
G C Farrell, and
G A Cash, and
L W Powell
January 1979,
Drug metabolism reviews,
W G Cooksley, and
G C Farrell, and
G A Cash, and
L W Powell
July 1995,
The Journal of clinical endocrinology and metabolism,
W G Cooksley, and
G C Farrell, and
G A Cash, and
L W Powell
May 1990,
Xenobiotica; the fate of foreign compounds in biological systems,
W G Cooksley, and
G C Farrell, and
G A Cash, and
L W Powell
January 1985,
Scandinavian journal of clinical and laboratory investigation. Supplementum,
W G Cooksley, and
G C Farrell, and
G A Cash, and
L W Powell
May 2013,
Current cardiology reports,
W G Cooksley, and
G C Farrell, and
G A Cash, and
L W Powell
January 1974,
Clinical pharmacology and therapeutics,
W G Cooksley, and
G C Farrell, and
G A Cash, and
L W Powell
January 1952,
Il Policlinico. Sezione pratica,
W G Cooksley, and
G C Farrell, and
G A Cash, and
L W Powell
January 2000,
Contributions to nephrology,
